转移性结直肠癌的临床实践新ESMO指南 - - 对全身治疗变化的评论
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
|December 29, 2023
概括
更新的欧洲医学瘤学会指南为转移性结直肠癌 (mCRC) 治疗提供了新的见解. 本评论强调了不可切割的mCRC全身治疗的关键变化,这对于患者治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 临床指南 临床指南
背景情况:
- 欧洲医学瘤学会 (ESMO) 发布了转移性结直肠癌 (mCRC) 的最新指南.
- 以前的指导方针发表于六年前,需要修订以反映进步.
- 重要的更新包括分子瘤测试,诊断和治疗程序以及新药.
研究的目的:
- 为mCRC.提供对新发布的ESMO指南的评论.
- 突出更新指南中最重要的变化.
- 专注于对不可切除的转移性结直肠癌的全身治疗的现状.
主要方法:
- 对mCRC的更新ESMO指南的审查和分析.
- 识别和讨论诊断和治疗建议中的关键修改.
- 专注于不可切除疾病的全身治疗策略.
主要成果:
- 更新的指南包括了分子瘤检测协议的变化.
- 实施了新的诊断和治疗程序.
- 这些指导方针涉及对mCRC新注册药物的整合.
结论:
- 对于有效的mCRC管理,了解更新的ESMO指南至关重要.
- 该指南的关键变化影响了治疗策略,特别是在无法切除的病例中.
- 评论强调了系统治疗在mCRC治疗方面的进步的重要性.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Barrett Esophagus-II: Clinical Manifestations and Management
154
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
154
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


